1. Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
    Jingwei Yao et al, 2020, Frontiers in Pharmacology CrossRef
  2. Challenges of Endocrine Therapy in Breast Cancer
    Sepideh Mansouri et al, 2017, Cancer Genetics and Psychotherapy CrossRef
  3. Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line
    Yongxi Tong et al, 2019, Experimental and Therapeutic Medicine CrossRef
  4. Protein Kinase Targets in Breast Cancer
    Marilina García-Aranda et al, 2017, International Journal of Molecular Sciences CrossRef
  5. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation
    Emily M Fox et al, 2013, Breast Cancer Research CrossRef
  6. A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells
    Esther Moreno et al, 2014, European Journal of Pharmaceutical Sciences CrossRef
  7. C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer
    Fenglin Zang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  8. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer
    Luis J. Schwarz et al, 2014, Journal of Clinical Investigation CrossRef
  9. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
    Shanliang Zhong et al, 2016, Oncotarget CrossRef
  10. Future perspectives for mTOR inhibitors in renal cell cancer treatment
    Anna M Czarnecka et al, 2015, Future Oncology CrossRef
  11. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug
    Ghadier Matariek et al, 2022, European Journal of Medical and Health Sciences CrossRef
  12. Anticancer mechanisms and clinical application of alkylphospholipids
    Wim J. van Blitterswijk et al, 2013, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
  13. Expression and Regulation of Prostate Apoptosis Response-4 (Par-4) in Human Glioma Stem Cells in Drug-Induced Apoptosis
    Jayashree C. Jagtap et al, 2014, PLoS ONE CrossRef
  14. Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
    Sara Kangaspeska et al, 2016, BMC Cancer CrossRef
  15. Antiproliferative Effect of ASC-J9 Delivered by PLGA Nanoparticles against Estrogen-Dependent Breast Cancer Cells
    Paolo Verderio et al, 2014, Molecular Pharmaceutics CrossRef
  16. Systemic Efficacy of Sirolimus via the ERBB Signaling Pathway in Breast Cancer
    Shinuk Kim, 2022, Processes CrossRef
  17. Prognostic Role of Human Epidermal Growth Factor Receptor 2 Status in Premenopausal Early Breast Cancer Treated With Adjuvant Tamoxifen
    Icro Meattini et al, 2013, Clinical Breast Cancer CrossRef
  18. MED1 may explain the interaction between receptor tyrosine kinases and ERα66 in the complicated network of Tamoxifen resistance
    Sepideh Mansouri et al, 2017, European Journal of Pharmacology CrossRef
  19. Dimethylsphingosine and miltefosine induce apoptosis in lung adenocarcinoma A549 cells in a synergistic manner
    Veselina Uzunova et al, 2019, Chemico-Biological Interactions CrossRef
  20. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
    Parham Jabbarzadeh Kaboli et al, 2020, Pharmacological Research CrossRef
  21. Long Non-coding RNAs and Cancer Cells’ Drug Resistance: An Unexpected Connection
    Perla Pucci et al, 2020, The Chemical Biology of Long Noncoding RNAs CrossRef
  22. Secretory prostate apoptosis response (Par)‐4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen‐induced cell death
    Jayashree C. Jagtap et al, 2015, FEBS Open Bio CrossRef
  23. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
    Chihua Wu et al, 2016, Medical Science Monitor CrossRef
  24. Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents
    Md. Maqusood Alam et al, 2018, Archives of Pharmacal Research CrossRef